Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lind

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
Ophthalmology|December 22, 2021
Primary Open-Angle Glaucoma Preferred Practice Pattern®Steven J Gedde, Kateki Vinod, Martha M Wright, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2012
Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trialR Fiocca, L Mastracci, S E Attwood, et al.
Allergy|February 17, 2012
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohortN Ballardini, I Kull, T Lind, et al.
Ophthalmology|December 22, 2021
Primary Angle-Closure Disease Preferred Practice Pattern®Steven J Gedde, Philip P Chen, Kelly W Muir, et al.
Scandinavian Journal of Gastroenterology|August 1, 1985
The rate of healing of duodenal ulcers during omeprazole treatmentJ Naesdal, T Lind, J Bergsåker-Aspöy, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?N J Talley, N Vakil, K Lauritsen, et al.
Ophthalmology|December 22, 2021
Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®Steven J Gedde, John T Lind, Martha M Wright, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2001
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 monthsN J Talley, K Lauritsen, H Tunturi-Hihnala, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 studyF Mégraud, N Lehn, T Lind, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Ophthalmology|December 22, 2021
Primary Open-Angle Glaucoma Preferred Practice Pattern®Steven J Gedde, Kateki Vinod, Martha M Wright, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2012
Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trialR Fiocca, L Mastracci, S E Attwood, et al.
Allergy|February 17, 2012
Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohortN Ballardini, I Kull, T Lind, et al.
Ophthalmology|December 22, 2021
Primary Angle-Closure Disease Preferred Practice Pattern®Steven J Gedde, Philip P Chen, Kelly W Muir, et al.
Scandinavian Journal of Gastroenterology|August 1, 1985
The rate of healing of duodenal ulcers during omeprazole treatmentJ Naesdal, T Lind, J Bergsåker-Aspöy, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?N J Talley, N Vakil, K Lauritsen, et al.
Ophthalmology|December 22, 2021
Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®Steven J Gedde, John T Lind, Martha M Wright, et al.
Alimentary Pharmacology & Therapeutics|February 24, 2001
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 monthsN J Talley, K Lauritsen, H Tunturi-Hihnala, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 studyF Mégraud, N Lehn, T Lind, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
Pageof 26